Allstocks.com's Bulletin Board Post A Reply
my profile login | register | search | faq | forum home

» Allstocks.com's Bulletin Board » Hot Stocks Free for All ! » Stop Smoking Without Nicotine???? » Post A Reply

Post A Reply
Login Name:
Password:
Message Icon: Icon 1     Icon 2     Icon 3     Icon 4     Icon 5     Icon 6     Icon 7    
Icon 8     Icon 9     Icon 10     Icon 11     Icon 12     Icon 13     Icon 14    
Message:

HTML is not enabled.
UBB Code™ is enabled.

 

Instant Graemlins Instant UBB Code™
Smile   Frown   Embarrassed   Big Grin   Wink   Razz  
Cool   Roll Eyes   Mad   Eek!   Confused   BadOne  
Good Luck   More Crap   Wall Bang   Were Up   Were Down    
Insert URL Hyperlink - UBB Code™   Insert Email Address - UBB Code™
Bold - UBB Code™   Italics - UBB Code™
Quote - UBB Code™   Code Tag - UBB Code™
List Start - UBB Code™   List Item - UBB Code™
List End - UBB Code™   Image - UBB Code™

What is UBB Code™?
Options


Disable Graemlins in this post.


 


T O P I C     R E V I E W
HouseGuest  - posted

Nicodrops, Inc. (Pink Sheets:NCDP), developer of the world's first drug-free, non-nicotine smoking cessation lozenge, announced today it has formally received approval from the Canadian Food and Drug Administration for their smoking cessation lozenge. The Canadian FDA Approval Drug Identification Number (DIN) 00245097 was issued through the Therapeutic Products Directorate of the Health Canada, FDA. The DIN number now permits Nicodrops to sell its products in the Canadian market.


Stop Smoking Without Nicotine : http://www.nicodrops.ca/html/buy_nicodrops.php


 

Kaboo!  - posted
Commit lozenge is the best. Everything else? Not so much.

quote:
Originally posted by HouseGuest:

Nicodrops, Inc. (Pink Sheets:NCDP), developer of the world's first drug-free, non-nicotine smoking cessation lozenge, announced today it has formally received approval from the Canadian Food and Drug Administration for their smoking cessation lozenge. The Canadian FDA Approval Drug Identification Number (DIN) 00245097 was issued through the Therapeutic Products Directorate of the Health Canada, FDA. The DIN number now permits Nicodrops to sell its products in the Canadian market.


Stop Smoking Without Nicotine : http://www.nicodrops.ca/html/buy_nicodrops.php



 

keithsan  - posted
carefull here, they don't really implicate the company but it could have bad effects.

Monday , December 13, 2004 16:27 ET

CHICAGO, Dec 13, 2004 (BUSINESS WIRE) --Zacks Investment Research, Inc. and one of Zacks' featured advisors, Donald H. Rowe, and Rowe's publication, The Wall Street Digest, have concluded an investigation into the fraudulent use of our respective brands for the illegal promotion of a California company, Nicodrops, Inc. (Pink Sheets:NCDP). It should be noted that Nicodrops management and their investment relations firm, The Cervelle Group, fully cooperated in the investigation, and we believe that they are wholly innocent in this matter.

"Essentially, what we were dealing with here is the spoofing of our widely known brand "Zacks.com Profit from the Pros" in an email by some unscrupulous party to promote the Nicodrops stock for their own personal gain." stated Stephen Reitmeister, EVP of Zacks' Internet Group. "Along with the illegal use of our brand they also falsely featured one of our newsletter experts, Donald Rowe of The Wall Street Digest. The obvious intent here was to use 2 respected names in the investment industry to give their promotion the air of respectability. Neither Donald Rowe nor Zacks.com has any form of recommendation on this stock."

The fraudulent e-mail was sent to an unknown database of investors. Zacks' network administrators have determined that the investment research firm's site security was never compromised during the incident, which took place on or about December 1, 2004. Zacks and The Wall Street Digest will pursue all legal recourse in this matter to bring the guilty parties to justice.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 to compile, analyze, and distribute investment research to both institutional and individual investors. The guiding principle behind Zacks work is the belief that investment experts, such as brokerage analysts and investment newsletter writers, have superior knowledge about how to invest successfully. The goal is to unlock these pros' profitable insights for individual investors hard-pressed to find this valuable information in one source. A free subscription to "Profit from the Pros" weekly e-mail newsletter provides the best way to use these experts' insights for more profitable investing. Register now for a free subscription to the Profit from the Pros newsletter at http://at.zacks.com/?id=87

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

SOURCE: Zacks.com



 

jordanreed  - posted
yikes! and i bought this today. the pr doesnt bother me but it may on the whole pps. lets hope not.
 



Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share